Li named medical and biological engineering fellow

BME professor Zong-Ming Li has been elected a fellow of the International Academy of Medical and Biological Engineering. Li is also a professor of the Department of Orthopaedic Surgery and Bio5 Institute.

“Being named to the 2024 class of the International Academy of Medical Biological Engineers is an incredible honor,” said Li, who is also the director of the Robert G. Volz, MD, Orthopaedic Research Laboratory and the Hand Research Laboratory. “It is a recognition from our peers and leaders in the field of biomedical engineering, showing the impact and importance of our work. It is a testament to the dedication, innovation and collaboration that underpin our efforts to improve health care outcomes through engineering solutions.”

Li’s research focuses on bioengineering studies of the hand, with clinical applications for carpal tunnel syndrome and wrist osteoarthritis. He recently invented a device to relieve symptoms caused by carpal tunnel syndrome.

“Carpal tunnel syndrome is a highly prevalent problem, and translating our findings to benefit patients is extremely satisfying,” said Li.

Li’s solution is novel in that it targets the median nerve, whereas existing braces only stabilize the wrist. About half a million U.S. patients seek surgery for CTS every year, and surgery is not the solution for everyone, Li said. The Rheumatology Research Foundation estimates that up to 10 million Americans have CTS. That leaves many who don’t choose surgery but also don’t find meaningful relief.

“We have proven our concept is sound. Next is finding the most intelligent implementation,” Li said.